“Design and Rational of the OPTIMA Study: Retreatment or Step-Up Therapy With Omalizumab in Patients With Chronic Idiopathic Spontaneous Urticaria (CIU CSU)”. SKIN The Journal of Cutaneous Medicine, vol. 1, no. 3.1, Oct. 2017, p. s125, https://doi.org/10.25251/skin.1.supp.124.